This inventor holds 3 USPTO granted patents. Top assignee: Wyeth. Active years: 2004-2008.
Company Filing History:
Years Active: 2004-2008
Title: Maria Papamichelakis: Innovator in Pharmaceutical Chemistry
Introduction
Maria Papamichelakis is a distinguished inventor based in Montreal, Canada. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 3 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Among her latest patents, one notable invention is titled "Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof." This invention focuses on methods for preparing 4-substituted quinoline compounds, which serve as intermediates in the manufacture of receptor tyrosine kinase inhibitors. The compounds are essential for developing new therapeutic agents. Another significant patent is for the "Preparation and purification of antiviral disulfonic acid disodium salt." This invention outlines a new process for producing an antiviral compound, which has potential applications in treating various viral infections.
Career Highlights
Maria is currently employed at Wyeth, a leading pharmaceutical company known for its commitment to innovation and research. Her role at Wyeth allows her to work on cutting-edge projects that aim to improve healthcare outcomes through advanced medicinal chemistry.
Collaborations
Throughout her career, Maria has collaborated with several talented individuals, including Silvio Iera and Christopher Demerson. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of her projects.
Conclusion
Maria Papamichelakis is a remarkable inventor whose work in pharmaceutical chemistry continues to impact the field significantly. Her innovative patents and collaborations highlight her dedication to advancing medical science.